Mental Health News and Research

Latest Mental Health News and Research

Depression among type 2 diabetes rural Appalachian clinic attendees

In Appalachia, diabetes hits hard. Depression does, too. Together, they form a difficult pair to beat.

28 May 2007

Restrictive medical studies exclude blacks and women

Treatment studies that exclude the homeless, illicit drug users or people with mental problems disproportionately curb the number of African-Americans and/or women eligible to participate in medical research, according to a new study from investigators at Stanford University.

28 May 2007

Lesbian/gay parenting

The birth of Mary Cheney's son today will create great public interest in same-sex parenting.

28 May 2007

Researchers identify a function of neuregulin1 - impact on schizophrenia

Cold Spring Harbor Laboratory (CSHL) researchers have identified a function of neuregulin1 (NRG1), a gene previously linked to schizophrenia but whose role in the disease was unknown.

28 May 2007

Tracing the path of depression

David Nutt, Professor of Psychopharmacology, said: "The development of one of these radioactive tracers to enable the study of noradrenaline and its related processes in those suffering depression is critical to our proper understanding of this disease.

27 May 2007

Most teens' mental health unaffected by nonmarital sex

For a decade, the legislative push for "abstinence only" sex education has suggested that nonmarital sex negatively affects a teen's mental health.

24 May 2007

Study of Aripiprazole in adolescents with schizophrenia

In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.

24 May 2007

Clinical study results on bifeprunox for schizophrenia

Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox, an investigational treatment for adult patients diagnosed with schizophrenia, at the 2007 annual meeting of the American Psychiatric Association.

24 May 2007

Antibiotics are highly effective for treating Lyme disease

A guideline developed by the American Academy of Neurology finds conventionally recommended courses of antibiotics are highly effective for treating nervous system Lyme disease.

24 May 2007

Is self-esteem overrated?

Many regard heightened self-esteem as a worthy aim, but others worry that its significance and value are overrated, reports the June 2007 issue of the Harvard Mental Health Letter .

24 May 2007

Check and balance for neuron activity provides insight into schizophrenia, seizures

Two genes important for human development and implicated in cancer and schizophrenia also help keep a healthy balance between excitation and inhibition of brain cells, researchers say.

24 May 2007

African-Americans perceive people with extreme health problems as less productive and valuable

African Americans appear to perceive people with extreme health problems as less productive or valuable according to a study published in the Journal of Clinical Epidemiology.

24 May 2007

Veterans with extreme mixed handedness and high combat exposure five times more likely to have PTSD

A recent study conducted by investigators with the Geisinger Center for Health Research shows a clear link between combat veterans' use of both hands for common tasks and the likelihood that they will experience post-traumatic stress disorder (PTSD).

24 May 2007

Ramelteon does not impair balance, mobility or memory performance in older adults with insomnia

A new study presented today showed that ramelteon did not impair middle-of-the-night balance, mobility or memory performance in older adults with insomnia, relative to placebo.

24 May 2007

Lupin receives FDA approval for Ziprasidone Hydrochloride capsules

Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.

24 May 2007

Iloperidone shows promise for Akathisia

According to study results presented at the 2007 American Psychiatric Association annual meeting, iloperidone, an investigational atypical antipsychotic, was shown to have a favorable akathisia profile.

24 May 2007

Efficacy and safety of Aripiprazole as adjunctive therapy in major depressive disorder

In adults with major depressive disorder, adding aripiprazole to antidepressant therapy (ADT) resulted in significant improvement in the primary endpoint, the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score.

24 May 2007

Am I exercising too much?

You run in the morning, train for your next marathon at night despite a nagging injury, and head to the gym to weight train in your free time. Missing a workout is not an option.

24 May 2007

Yoga shows promise in improving symptoms associated with depression, anxiety and epilepsy

Researchers at Boston University School of Medicine (BUSM) and McLean Hospital have found that practicing yoga may elevate brain gamma-aminobutyric (GABA) levels, the brain's primary inhibitory neurotransmitter.

23 May 2007